284 related articles for article (PubMed ID: 19333952)
1. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.
Faurschou M; Mellemkjaer L; Sorensen IJ; Svalgaard Thomsen B; Dreyer L; Baslund B
Arthritis Rheum; 2009 Apr; 60(4):1187-92. PubMed ID: 19333952
[TBL] [Abstract][Full Text] [Related]
2. High risk of ischemic heart disease in patients with lupus nephritis.
Faurschou M; Mellemkjaer L; Starklint H; Kamper AL; Tarp U; Voss A; Jacobsen S
J Rheumatol; 2011 Nov; 38(11):2400-5. PubMed ID: 21885497
[TBL] [Abstract][Full Text] [Related]
3. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
4. Cancer preceding Wegener's granulomatosis: a case-control study.
Faurschou M; Mellemkjaer L; Sorensen IJ; Thomsen BS; Dreyer L; Baslund B
Rheumatology (Oxford); 2009 Apr; 48(4):421-4. PubMed ID: 19213850
[TBL] [Abstract][Full Text] [Related]
5. No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
Holmqvist ME; Wedrén S; Jacobsson LT; Klareskog L; Nyberg F; Rantapää-Dahlqvist S; Alfredsson L; Askling J
Arthritis Rheum; 2009 Oct; 60(10):2861-9. PubMed ID: 19790058
[TBL] [Abstract][Full Text] [Related]
6. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
Abdou NI; Kullman GJ; Hoffman GS; Sharp GC; Specks U; McDonald T; Garrity J; Goeken JA; Allen NB
J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
[TBL] [Abstract][Full Text] [Related]
7. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease.
Knight A; Sandin S; Askling J
Arthritis Rheum; 2008 Jan; 58(1):302-7. PubMed ID: 18163522
[TBL] [Abstract][Full Text] [Related]
8. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease.
Ludvigsson JF; James S; Askling J; Stenestrand U; Ingelsson E
Circulation; 2011 Feb; 123(5):483-90. PubMed ID: 21262996
[TBL] [Abstract][Full Text] [Related]
9. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Wegener's granulomatosis in northern Norway.
Koldingsnes W; Nossent H
Arthritis Rheum; 2000 Nov; 43(11):2481-7. PubMed ID: 11083271
[TBL] [Abstract][Full Text] [Related]
11. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.
Reinhold-Keller E; Beuge N; Latza U; de Groot K; Rudert H; Nölle B; Heller M; Gross WL
Arthritis Rheum; 2000 May; 43(5):1021-32. PubMed ID: 10817555
[TBL] [Abstract][Full Text] [Related]
12. Wegener's granulomatosis associated with renal cell carcinoma.
Tatsis E; Reinhold-Keller E; Steindorf K; Feller AC; Gross WL
Arthritis Rheum; 1999 Apr; 42(4):751-6. PubMed ID: 10211890
[TBL] [Abstract][Full Text] [Related]
13. Wegener's granulomatosis: the relationship between ocular and systemic disease.
Harper SL; Letko E; Samson CM; Zafirakis P; Sangwan V; Nguyen Q; Uy H; Baltatzis S; Foster CS
J Rheumatol; 2001 May; 28(5):1025-32. PubMed ID: 11361183
[TBL] [Abstract][Full Text] [Related]
14. Wegener's granulomatosis: epidemiological and clinical features in a South Australian study.
Hissaria P; Cai FZ; Ahern M; Smith M; Gillis D; Roberts-Thomson P
Intern Med J; 2008 Oct; 38(10):776-80. PubMed ID: 19143878
[TBL] [Abstract][Full Text] [Related]
15. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with Wegener's granulomatosis diagnosed in Finland in 1981-2000.
Takala JH; Kautiainen H; Leirisalo-Repo M
Scand J Rheumatol; 2010; 39(1):71-6. PubMed ID: 20132074
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
Gibson A; Stamp LK; Chapman PT; O'Donnell JL
Rheumatology (Oxford); 2006 May; 45(5):624-8. PubMed ID: 16368729
[TBL] [Abstract][Full Text] [Related]
18. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
Mohammad AJ; Jacobsson LT; Westman KW; Sturfelt G; Segelmark M
Rheumatology (Oxford); 2009 Dec; 48(12):1560-5. PubMed ID: 19797309
[TBL] [Abstract][Full Text] [Related]
19. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
20. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
Stone JH;
Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
